Ticker Details
Dyadic International, Inc.
IPO Date:	February 1, 2008
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$31.91M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.11 | 3.48%
Avg Daily Range (30 D):	$0.04 | 4.75%
Avg Daily Range (90 D):	$0.03 | 3.96%

Institutional Daily Volume
Avg Daily Volume:	.25M
Avg Daily Volume (30 D):	.05M
Avg Daily Volume (90 D):	.13M

Trade Size
Avg Trade Size (Sh.):	236
Avg Trade Size (Sh.) (30 D):	216
Avg Trade Size (Sh.) (90 D):	251

Institutional Trades
Total Institutional Trades:	20
Avg Institutional Trade:	$2.11M
Avg Institutional Trade (30 D):	$.84M
Avg Institutional Trade (90 D):	$.84M
Avg Institutional Trade Volume:	.35M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$4.07M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	600.59K

News

May 1, 2025 @ 7:00 PM Dyadic to Report First Quarter 2025 Financial Resu... Source: N/A

Mar 11, 2025 @ 9:28 AM Industrial Enzymes Global Industry Forecast Report... Source: Researchandmarkets.Com

Oct 9, 2024 @ 12:00 PM Dyadic Expands Global Presence with Participation ... Source: N/A

Jun 28, 2024 @ 12:30 PM Dyadic International, Inc. and Proliant Health and... Source: Dyadic International, Inc.

May 8, 2024 @ 12:30 PM Dyadic to Attend Industry and Investor Events in M... Source: Dyadic International, Inc.

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.23	$-.06	$-.23
Diluted EPS	$-.23	$-.06	$-.23
Revenue	$3.09M	$.57M	$3.09M
Gross Profit	$.77M	$.18M	$.77M
Net Income / Loss	$-7.36M	$-1.57M	$-7.36M
Operating Income / Loss	$-7.19M	$-1.54M	$-7.19M
Cost of Revenue	$2.32M	$.38M	$2.32M
Net Cash Flow	$-.66M	$-1.3M	$-.66M
PE Ratio